Portal de Periódicos da CAPES

Gender differences in C‐reactive protein, interleukin‐1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population‐based study

2008; Wiley; Volume: 25; Issue: 6 Linguagem: Inglês

10.1111/j.1464-5491.2008.02440.x

1464-5491

Juha Saltevo, Mauno Vanhala, Hannu Kautiainen, E Kumpusalo, Markku Laakso,

Adipose Tissue and Metabolism

We explored gender differences in the association of high-sensitivity C-reactive protein (hs-CRP), interleukin-1 receptor antagonist (IL-1Ra) and adiponectin with the metabolic syndrome (MetS) defined by the National Cholesterol Education Program (NCEP) and the International Diabetes Federation (IDF) criteria.A population-based study of 923 middle-aged subjects in Pieksämäki, East Finland.The prevalence of the MetS according to the IDF and NCEP definitions was 38% and 34% in men (N = 405) and 34% and 27% in women (N = 497), respectively. hs-CRP and IL-1Ra levels were higher in subjects with the MetS compared with those without the MetS in both sexes (P < 0.001). The levels of hs-CRP (P < 0.001) and IL-1Ra (P = 0.0016 for NCEP criteria, P = 0.0028 for IDF criteria) were significantly higher in women with MetS than in men with MetS. In contrast, in subjects without MetS, no gender differences in the levels of hs-CRP or IL-1Ra were found.Women with MetS, defined by the IDF or NCEP criteria, had higher levels of hs-CRP and IL-1Ra than did men with MetS. Thus, low-grade inflammation may contribute to the high risk of cardiovascular disease in women with MetS.